Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 4.22% | 153.21 | 0.0% | $2820.60m | |
| BNGO | BioNano Genomics, Inc. | -0.91% | 12.47 | 0.0% | $2656.95m | |
| GILD | Gilead Sciences, Inc. | -1.98% | 66.81 | 1.0% | $665.99m | |
| AMGN | Amgen, Inc. | -0.16% | 256.69 | 1.3% | $583.75m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.33% | 546.39 | 2.7% | $500.58m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.28% | 161.77 | 2.0% | $480.33m | |
| CRSP | CRISPR Therapeutics AG | -4.51% | 173.07 | 0.6% | $456.60m | |
| AXON | Axovant Sciences Ltd | 1.44% | 177.05 | 5.1% | $441.72m | |
| ILMN | Illumina, Inc. | -0.95% | 417.01 | 3.5% | $438.56m | |
| NVAX | Novavax, Inc. | -2.46% | 128.23 | 92.9% | $417.01m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.76% | 239.47 | 1.9% | $382.06m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.52% | 93.69 | 13.8% | $357.67m | |
| BIIB | Biogen, Inc. | -2.03% | 269.96 | 1.7% | $327.47m | |
| BNTX | BioNTech SE | -1.64% | 108.80 | 0.0% | $309.81m | |
| EXAS | EXACT Sciences Corp. | -7.14% | 142.94 | 19.6% | $248.79m |
Company Profile
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.